Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains one of the deadliest infectious diseases worldwide. Meanwhile, non-tuberculous mycobacteria (NTM) are an increasing global health concern. NTM infections often resemble TB clinically, which can lead to misdiagnosis and inappropriate therapy. Additionally, drug-resistant strains of M. tuberculosis and NTM exacerbate the global antimicrobial resistance crisis. A better understanding of the biology of mycobacterial pathogens and of the mechanisms underlying disease pathogenesis and transmission is critical to reduce their burden worldwide. This EMBO Workshop is the fourth in a successful series held at the Institut Pasteur in Paris, following the meetings organized in 2012, 2016, and 2022. It will bring together scientists, clinicians, public health experts, and representatives from industry and non-profit organizations, who will share recent insights into mycobacterial infections, from fundamental discoveries to translational research, and their practical implications. The program will cover mycobacterial evolution, physiology, metabolism, host–pathogen interactions, immune responses, mechanisms of drug evasion, therapeutic strategies, vaccines, and diagnostics. Emerging experimental models, computational approaches, and artificial intelligence will also be addressed, showing how recent technologies contribute to advancing mycobacterial research and interventions.
🧬 EMBO Workshop – The complexity of mycobacterial infections: from research to real-world impact
📅 14–18 Sept 2026, Paris
Tuberculosis & non-tuberculous mycobacteria at the heart of discussions: evolution, host–pathogen interactions, drug resistance.
🔗 meetings.embo.org/event/26-myc...
